Stay updated on NL-201 Monotherapy and With Pembrolizumab in Cancer Clinical Trial
Sign up to get notified when there's something new on the NL-201 Monotherapy and With Pembrolizumab in Cancer Clinical Trial page.

Latest updates to the NL-201 Monotherapy and With Pembrolizumab in Cancer Clinical Trial page
- Check7 days agoNo Change Detected
- Check13 days agoChange DetectedRecord history shows a new Revision: v3.4.2 was added and the prior funding-notice revision (v3.4.1) was removed. This reflects maintenance/versioning rather than substantive study content.SummaryDifference0.7%

- Check21 days agoChange DetectedAdded a banner notice about government funding and operating status, and updated the release version to v3.4.1, replacing v3.4.0.SummaryDifference0.7%

- Check28 days agoChange DetectedMinor UI updates on the history page, including a Show glossary option and color-coded indicators for additions and deletions, along with an updated version note (Revision: v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.9%

- Check42 days agoChange DetectedA new revision entry v3.3.4 was added to the history and the previous v3.3.3 entry was removed; this is a minor housekeeping update to the record history. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check63 days agoChange DetectedA new revision entry, Revision: v3.3.3, was added to the history, and the HHS Vulnerability Disclosure link and Revision: v3.3.2 were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check92 days agoChange DetectedFooter now shows Revision: v3.3.2, replacing the previous Revision: v3.2.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to NL-201 Monotherapy and With Pembrolizumab in Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the NL-201 Monotherapy and With Pembrolizumab in Cancer Clinical Trial page.